Стоит ли избегать azadirachta indica bark/seed extract при беременности? | VeriMom

What to use instead

Pregnancy-safe ingredients that serve a similar function:

FAQ

Безопасен ли azadirachta indica bark/seed extract при беременности?

ECHA/EU harmonised classification (Annex VI / Commission implementing entries) lists margosa extract (from kernels of Azadirachta indica, CAS 84696-25-3, specific extraction) with H361d (suspected toxic to reproduction) and H317 (skin sensitiser), which supports h=2 (suspected). Animal studies report developmental/reproductive effects (rodent studies of neem extracts showing fetal abnormalities and maternal/fetal endpoints), supporting a demonstrable mechanism related to bioactive limonoids (azadirachtin) rather than purely theoretical concerns. For topical cosmetic use systemic absorption is expected to be low but measurable, so exposure is graded as low (adult e=1). (Sources: ECHA harmonised CLP documents; rodent maternal/fetal studies.).

Безопасен ли azadirachta indica bark/seed extract при грудном вскармливании?

Same regulatory harmonised classification (H361d) applies and animal reproductive/developmental data indicate reproductive/developmental effects, so h remains 2. Mechanistic concern (azadirachtin/limonoids affecting reproductive biology) is demonstrated in animal models. Topical use leads to low but measurable systemic exposure in adults; therefore breastfeeding exposure is considered low (e=1) but not negligible — nursing infants could be secondarily exposed if systemic transfer occurs. No clear human lactation studies were located.

Безопасен ли azadirachta indica bark/seed extract для кожи малыша?

Hazard (h=2) driven by harmonised H361d listing for margosa/kernel extracts and supporting animal reproductive/developmental data. Mechanism (m=2) based on demonstrated reproductive/developmental effects of neem/seed extracts in animal studies implicating azadirachtin/limonoids. Exposure score increased by +1 for infants versus adults because infant skin has higher absorption and immature barrier; therefore e=2 for baby skin when applied topically. Note: harmonised classification explicitly refers to kernel extracts prepared by specified extraction methods — different parts (bark vs kernels) and extraction methods can alter composition and thus risk; this distinction is a critical data gap.

Как VeriMom оценивает azadirachta indica bark/seed extract?

VeriMom оценивает azadirachta indica bark/seed extract в 20/100 (высокий риск) на основе EU CosIng, классификаций ECHA и исследований PubMed.

Какие безопасные альтернативы azadirachta indica bark/seed extract при беременности?

См. наш список безопасных альтернатив azadirachta indica bark/seed extract с аналогичной функцией и классификацией без известных рисков.